A detailed history of Legal & General Group PLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,979,330 shares of ZBH stock, worth $223 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,979,330
Previous 1,979,330 -0.0%
Holding current value
$223 Million
Previous $214 Million -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$104.47 - $116.17 $465,936 - $518,118
4,460 Added 0.23%
1,979,330 $214 Million
Q2 2024

Aug 14, 2024

SELL
$106.25 - $130.01 $13.8 Million - $16.9 Million
-130,158 Reduced 6.18%
1,974,870 $214 Million
Q1 2024

May 14, 2024

SELL
$119.98 - $132.61 $3.93 Million - $4.34 Million
-32,721 Reduced 1.53%
2,105,028 $278 Million
Q4 2023

Feb 15, 2024

BUY
$102.72 - $121.7 $24.5 Million - $29 Million
238,418 Added 12.55%
2,137,749 $260 Million
Q3 2023

Nov 14, 2023

SELL
$110.76 - $143.18 $516,473 - $667,648
-4,663 Reduced 0.24%
1,899,331 $213 Million
Q2 2023

Aug 14, 2023

BUY
$126.43 - $145.6 $27.7 Million - $31.9 Million
219,309 Added 13.02%
1,903,994 $277 Million
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $1.03 Million - $1.1 Million
8,423 Added 0.5%
1,684,685 $218 Million
Q4 2022

Feb 14, 2023

SELL
$104.7 - $128.4 $7.74 Million - $9.49 Million
-73,944 Reduced 4.22%
1,676,262 $214 Million
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $4.37 Million - $5.13 Million
-43,026 Reduced 2.4%
1,750,206 $183 Million
Q2 2022

Aug 22, 2022

BUY
$102.23 - $133.85 $6.35 Million - $8.32 Million
62,127 Added 3.59%
1,793,232 $188 Million
Q1 2022

May 16, 2022

BUY
$108.42 - $129.58 $17.3 Million - $20.7 Million
159,553 Added 10.15%
1,731,105 $221 Million
Q4 2021

Feb 14, 2022

SELL
$115.43 - $146.63 $7.4 Million - $9.4 Million
-64,113 Reduced 3.92%
1,571,552 $200 Million
Q3 2021

Nov 15, 2021

BUY
$136.35 - $158.76 $11.5 Million - $13.4 Million
84,250 Added 5.43%
1,635,665 $239 Million
Q2 2021

Aug 12, 2021

BUY
$152.95 - $173.41 $12.2 Million - $13.9 Million
80,002 Added 5.44%
1,551,415 $249 Million
Q1 2021

May 17, 2021

SELL
$148.16 - $159.71 $3.36 Million - $3.63 Million
-22,707 Reduced 1.52%
1,471,413 $236 Million
Q4 2020

Feb 12, 2021

SELL
$128.25 - $151.41 $3.01 Million - $3.55 Million
-23,472 Reduced 1.55%
1,494,120 $230 Million
Q3 2020

Nov 13, 2020

SELL
$113.59 - $141.68 $1.2 Million - $1.5 Million
-10,581 Reduced 0.69%
1,517,592 $207 Million
Q2 2020

Aug 14, 2020

BUY
$87.02 - $133.4 $1.58 Million - $2.42 Million
18,153 Added 1.2%
1,528,173 $182 Million
Q1 2020

May 14, 2020

BUY
$78.28 - $155.73 $3.72 Million - $7.41 Million
47,563 Added 3.25%
1,510,020 $153 Million
Q4 2019

Feb 13, 2020

BUY
$127.4 - $146.83 $7.65 Million - $8.82 Million
60,068 Added 4.28%
1,462,457 $219 Million
Q3 2019

Nov 13, 2019

SELL
$113.33 - $138.46 $656,407 - $801,960
-5,792 Reduced 0.41%
1,402,389 $192 Million
Q2 2019

Aug 14, 2019

BUY
$108.87 - $125.09 $4.01 Million - $4.6 Million
36,810 Added 2.68%
1,408,181 $166 Million
Q1 2019

May 15, 2019

BUY
$97.5 - $125.79 $23.1 Million - $29.8 Million
237,296 Added 20.92%
1,371,371 $175 Million
Q4 2018

Feb 15, 2019

BUY
$94.4 - $126.76 $8.72 Million - $11.7 Million
92,327 Added 8.86%
1,134,075 $118 Million
Q3 2018

Nov 20, 2018

BUY
$108.41 - $127.64 $6.29 Million - $7.41 Million
58,022 Added 5.9%
1,041,748 $137 Million
Q2 2018

Aug 10, 2018

BUY
$102.12 - $114.04 $2.23 Million - $2.49 Million
21,825 Added 2.27%
983,726 $110 Million
Q1 2018

May 17, 2018

SELL
$104.31 - $124.46 $5.54 Million - $6.61 Million
-53,113 Reduced 5.23%
961,901 $105 Million
Q4 2017

Feb 13, 2018

BUY
$105.55 - $120.83 $107 Million - $123 Million
1,015,014
1,015,014 $122 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.6B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.